NCT02368522View on ClinicalTrials.gov

Comparative Assessment of Utilization of Antiviral Therapies in Hepatitis C and Effectiveness of Daclatasvir-containing Regimens in Real-life Clinical Care in Europe (CMPASS-EU)

CompletedOBSERVATIONAL
Enrollment

920

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

February 28, 2017

Study Completion Date

February 28, 2017

Conditions
Hepatitis
Trial Locations (1)

20099

Local Institution, Hamburg

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY